A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition ...
Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...
If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
Syntax Systems, a global technology solutions and services provider for cloud application implementation and management, has officially acquired Montreal-based Beyond Technologies, enabling the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results